These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 32100015)

  • 21. Overview of Fusion Detection Strategies Using Next-Generation Sequencing.
    Schröder J; Kumar A; Wong SQ
    Methods Mol Biol; 2019; 1908():125-138. PubMed ID: 30649725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Characterization of Pediatric Sarcomas by Targeted RNA Sequencing.
    Avenarius MR; Miller CR; Arnold MA; Koo S; Roberts R; Hobby M; Grossman T; Moyer Y; Wilson RK; Mardis ER; Gastier-Foster JM; Pfau RB
    J Mol Diagn; 2020 Oct; 22(10):1238-1245. PubMed ID: 32745614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors.
    Reeser JW; Martin D; Miya J; Kautto EA; Lyon E; Zhu E; Wing MR; Smith A; Reeder M; Samorodnitsky E; Parks H; Naik KR; Gozgit J; Nowacki N; Davies KD; Varella-Garcia M; Yu L; Freud AG; Coleman J; Aisner DL; Roychowdhury S
    J Mol Diagn; 2017 Sep; 19(5):682-696. PubMed ID: 28802831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New fusion sarcomas: histopathology and clinical significance of selected entities.
    Miettinen M; Felisiak-Golabek A; Luiña Contreras A; Glod J; Kaplan RN; Killian JK; Lasota J
    Hum Pathol; 2019 Apr; 86():57-65. PubMed ID: 30633925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ChildSeq-RNA: A next-generation sequencing-based diagnostic assay to identify known fusion transcripts in childhood sarcomas.
    Qadir MA; Zhan SH; Kwok B; Bruestle J; Drees B; Popescu OE; Sorensen PH
    J Mol Diagn; 2014 May; 16(3):361-70. PubMed ID: 24517889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Profiling of Hyalinizing Clear Cell Carcinomas Revealed a Subset of Tumors Harboring a Novel EWSR1-CREM Fusion: Report of 3 Cases.
    Chapman E; Skalova A; Ptakova N; Martinek P; Goytain A; Tucker T; Xiong W; Leader M; Kudlow BA; Haimes JD; Hayes MM; Bohus P; Miesbauerova M; Lee CH; Ng TL
    Am J Surg Pathol; 2018 Sep; 42(9):1182-1189. PubMed ID: 29975250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical validation of the tempus xT next-generation targeted oncology sequencing assay.
    Beaubier N; Tell R; Lau D; Parsons JR; Bush S; Perera J; Sorrells S; Baker T; Chang A; Michuda J; Iguartua C; MacNeil S; Shah K; Ellis P; Yeatts K; Mahon B; Taxter T; Bontrager M; Khan A; Huether R; Lefkofsky E; White KP
    Oncotarget; 2019 Mar; 10(24):2384-2396. PubMed ID: 31040929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted Next-Generation Sequencing for Detecting
    Afrin S; Zhang CRC; Meyer C; Stinson CL; Pham T; Bruxner TJC; Venn NC; Trahair TN; Sutton R; Marschalek R; Fink JL; Moore AS
    Mol Cancer Res; 2018 Feb; 16(2):279-285. PubMed ID: 29133595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.
    Takeuchi K; Choi YL; Soda M; Inamura K; Togashi Y; Hatano S; Enomoto M; Takada S; Yamashita Y; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y; Mano H
    Clin Cancer Res; 2008 Oct; 14(20):6618-24. PubMed ID: 18927303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.
    Garcia EP; Minkovsky A; Jia Y; Ducar MD; Shivdasani P; Gong X; Ligon AH; Sholl LM; Kuo FC; MacConaill LE; Lindeman NI; Dong F
    Arch Pathol Lab Med; 2017 Jun; 141(6):751-758. PubMed ID: 28557599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples.
    Angell TE; Wirth LJ; Cabanillas ME; Shindo ML; Cibas ES; Babiarz JE; Hao Y; Kim SY; Walsh PS; Huang J; Kloos RT; Kennedy GC; Waguespack SG
    Front Endocrinol (Lausanne); 2019; 10():612. PubMed ID: 31572297
    [No Abstract]   [Full Text] [Related]  

  • 32. Anchored multiplex PCR for targeted next-generation sequencing.
    Zheng Z; Liebers M; Zhelyazkova B; Cao Y; Panditi D; Lynch KD; Chen J; Robinson HE; Shim HS; Chmielecki J; Pao W; Engelman JA; Iafrate AJ; Le LP
    Nat Med; 2014 Dec; 20(12):1479-84. PubMed ID: 25384085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
    Gao Q; Liang WW; Foltz SM; Mutharasu G; Jayasinghe RG; Cao S; Liao WW; Reynolds SM; Wyczalkowski MA; Yao L; Yu L; Sun SQ; ; ; Chen K; Lazar AJ; Fields RC; Wendl MC; Van Tine BA; Vij R; Chen F; Nykter M; Shmulevich I; Ding L
    Cell Rep; 2018 Apr; 23(1):227-238.e3. PubMed ID: 29617662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiplex Diagnosis of Oncogenic Fusion and MET Exon Skipping by Molecular Counting Using Formalin-Fixed Paraffin Embedded Lung Adenocarcinoma Tissues.
    Sunami K; Furuta K; Tsuta K; Sasada S; Izumo T; Nakaoku T; Shimada Y; Saito M; Nokihara H; Watanabe S; Ohe Y; Kohno T
    J Thorac Oncol; 2016 Feb; 11(2):203-12. PubMed ID: 26845116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of 22 common leukemic fusion genes using a single-step multiplex qRT-PCR-based assay.
    Lyu X; Wang X; Zhang L; Chen Z; Zhao Y; Hu J; Fan R; Song Y
    Diagn Pathol; 2017 Jul; 12(1):55. PubMed ID: 28743306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib.
    Eismann J; Heng YJ; Waldschmidt JM; Vlachos IS; Gray KP; Matulonis UA; Konstantinopoulos PA; Murphy CJ; Nabavi S; Wulf GM
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):503-514. PubMed ID: 31745703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples.
    Kurobe M; Kojima T; Nishimura K; Kandori S; Kawahara T; Yoshino T; Ueno S; Iizumi Y; Mitsuzuka K; Arai Y; Tsuruta H; Habuchi T; Kobayashi T; Matsui Y; Ogawa O; Sugimoto M; Kakehi Y; Nagumo Y; Tsutsumi M; Oikawa T; Kikuchi K; Nishiyama H
    PLoS One; 2016; 11(12):e0165109. PubMed ID: 27930669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate Cancer.
    Wagle MC; Castillo J; Srinivasan S; Holcomb T; Yuen KC; Kadel EE; Mariathasan S; Halligan DL; Carr AR; Bylesjo M; McAdam PR; Lynagh S; Marien KM; Kockx M; Waumans Y; Huang SA; Lackner MR; Mounir Z
    Cancer Immunol Res; 2020 Jul; 8(7):844-850. PubMed ID: 32321776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistical algorithms improve accuracy of gene fusion detection.
    Hsieh G; Bierman R; Szabo L; Lee AG; Freeman DE; Watson N; Sweet-Cordero EA; Salzman J
    Nucleic Acids Res; 2017 Jul; 45(13):e126. PubMed ID: 28541529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data.
    Okonechnikov K; Imai-Matsushima A; Paul L; Seitz A; Meyer TF; Garcia-Alcalde F
    PLoS One; 2016; 11(12):e0167417. PubMed ID: 27907167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.